About the Study

This study is investigating the long-term safety, tolerability, and efficacy of a new oral medication in subjects with a diagnosis of schizophrenia. This study is sponsored by Karuna Pharmaceuticals.

Length of Study:  up to 52 weeks

Eligibility 

You may be eligible to participate in this study if you:

• are between the ages of 18 – 65 years old
• have been diagnosed with schizophrenia
• have been on the same oral antipsychotic for 8 weeks before the screening visit

If chosen for this study, you will be compensated for every study visit that you complete and we can provide transportation if needed. 

If you are interested in participating in this clinical trial, please call our friendly staff at 773-989-8313 ext. 116 today. You can also fill out the contact form below.